Revised Disclosure Reporting Recommendations From the International Committee of Medical Journal Editors (ICMJE)
The ICMJE recently updated the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. The updates include concrete advice to help authors provide accurate and full disclosures of all relationships and activities that may be perceived to influence their work. Alongside these changes, the ICMJE proposed changes to their disclosure form to further promote transparency and trust (Taichman DB, et al. 2020 ). Notably, the ICMJE proposes including a checklist designed for authors to review their disclosures and have confidence that they supplied the right level of information. The ICMJE also reports that member journals will begin to accept disclosures from web-based repositories, such as Convey®. The ICMJE will review feedback and comments on the form until April 30, 2020.
Open Access Journal Tool for Industry (OA-JTI)
Open access options can vary by funding source as well as by journal, and this information is not readily available on journal websites. To address this gap, MPIP created the Open Access Journal Tool for Industry (OA-JTI), a free and unique resource to help find open access publishing options for industry-sponsored research.
Users can filter their search by therapeutic area, copyright policy, publisher, title, open access article policy, and open access journal publishing model.
Enter your email address below and select "Sign me up" to receive updates on MPIP initiatives.
Growing advocacy for transparency and access to results of clinical trials has prompted considerable debate on the topic of open access publishing and highlighted a lack of common understanding of what open access is, why it is important, and how it works. Consistent with our goal of promoting greater transparency in industry-sponsored publications, MPIP has developed a reference site to raise awareness of open access, including its importance in meeting shared transparency goals.
Transparency and Credibility of Industry-Sponsored Clinical Trial Publications: A Survey of Journal Editors, published in CMRO, reports on benchmark research conducted to assess how medical journal editors perceived changes in transparency and credibility of industry-sponsored clinical trial publications over a 5-year period (from 2010 to 2015).
Developed in collaboration with medical journal editors, MPIP Insights for Authors is a series of short videos to support authors and publications professionals in developing industry–sponsored research publications. MPIP Insights for Authors contains guidance and best practices for all stages of the publication process, from first draft development to navigating the peer-review system.
Transparency Matters is a global educational platform and call to action that raises awareness of the importance of transparency in reporting the results of industry-sponsored research and its impact on credibility. As part of Transparency Matters, MPIP launched What Transparency Means to Me to broaden the conversation around transparency in medical publications, promote best practices, and engage interested parties in this important mission. This platform creates a space for those involved in reporting research results to share their perspectives on why transparency is essential to patient care, scientific understanding, and credibility, and how it can best be achieved when disclosing research results.
Medical Publishing Insights & Practices (MPIP) was founded in 2008 by members of the pharmaceutical industry and the International Society for Medical Publication Professionals (ISMPP) to elevate trust, transparency, and integrity in reporting the results of industry-sponsored research. The major goal of MPIP is to encourage more effective partnership between trial sponsors and medical journals to raise standards in medical publications and expand access to research results.